Free tool
FAERS Monitor: Lanoxin Pediatric
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 009330 or its brand name (Lanoxin Pediatric, Digoxin). Reports on generic versions are filed under their own applications.
Reports
71,872
Serious
59,472
83% of reports
Hospitalization
36,512
Death reported
13,846
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea6,218
- nausea4,866
- dizziness4,566
- fatigue4,288
- atrial fibrillation4,066
- diarrhoea3,896
- asthenia3,662
- death3,471
- vomiting3,443
- hypotension3,258
- cardiac failure congestive3,144
- pain3,062
- fall2,957
- drug interaction2,890
- pneumonia2,775
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,671 |
| 2005 | 2,602 |
| 2006 | 2,533 |
| 2007 | 2,008 |
| 2008 | 4,394 |
| 2009 | 3,558 |
| 2010 | 3,377 |
| 2011 | 4,017 |
| 2012 | 3,946 |
| 2013 | 3,401 |
| 2014 | 4,322 |
| 2015 | 4,309 |
| 2016 | 4,283 |
| 2017 | 4,071 |
| 2018 | 3,910 |
| 2019 | 3,317 |
| 2020 | 2,990 |
| 2021 | 2,278 |
| 2022 | 1,862 |
| 2023 | 2,305 |
| 2024 | 2,178 |
| 2025 | 2,084 |
| 2026 | 1,449 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,982,287 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| atrial fibrillationSignal | 4,066 | 12.7 | 12.3 | 42,207 |
| cardiac failure congestiveSignal | 3,144 | 11.9 | 11.5 | 30,203 |
| drug interactionSignal | 2,890 | 5.4 | 5.2 | 10,277 |
| hypotensionSignal | 3,258 | 4.8 | 4.7 | 9,778 |
| dyspnoeaSignal | 6,218 | 3.2 | 3.2 | 9,779 |
| astheniaSignal | 3,662 | 2.9 | 2.8 | 4,491 |
| dizzinessSignal | 4,566 | 2.7 | 2.6 | 4,937 |
| fallSignal | 2,957 | 2.6 | 2.5 | 2,967 |
| pneumoniaSignal | 2,775 | 2.5 | 2.4 | 2,563 |
| vomitingSignal | 3,443 | 2.2 | 2.1 | 2,153 |
| nausea | 4,866 | 1.8 | 1.8 | 1,800 |
| diarrhoea | 3,896 | 1.8 | 1.7 | 1,340 |
| fatigue | 4,288 | 1.6 | 1.6 | 1,037 |
| pain | 3,062 | 1.5 | 1.4 | 456 |
| death | 3,471 | 1.2 | 1.1 | 99 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.